Cargando…
Identification of a novel NAMPT inhibitor by CRISPR/Cas9 chemogenomic profiling in mammalian cells
Chemogenomic profiling is a powerful and unbiased approach to elucidate pharmacological targets and the mechanism of bioactive compounds. Until recently, genome-wide, high-resolution experiments of this nature have been limited to fungal systems due to lack of mammalian genome-wide deletion collecti...
Autores principales: | Estoppey, David, Hewett, Jeffrey W., Guy, Chantale T., Harrington, Edmund, Thomas, Jason R., Schirle, Markus, Cuttat, Rachel, Waldt, Annick, Gerrits, Bertran, Yang, Zinger, Schuierer, Sven, Pan, Xuewen, Xie, Kevin, Carbone, Walter, Knehr, Judith, Lindeman, Alicia, Russ, Carsten, Frias, Elizabeth, Hoffman, Gregory R., Varadarajan, Malini, Ramadan, Nadire, Reece-Hoyes, John S., Wang, Qiong, Chen, Xin, McAllister, Gregory, Roma, Guglielmo, Bouwmeester, Tewis, Hoepfner, Dominic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5311948/ https://www.ncbi.nlm.nih.gov/pubmed/28205648 http://dx.doi.org/10.1038/srep42728 |
Ejemplares similares
-
Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening
por: Kiessling, Michael K., et al.
Publicado: (2016) -
Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis
por: Wang, Zhong-Yi, et al.
Publicado: (2021) -
TDR Targets: a chemogenomics resource for neglected diseases
por: Magariños, María P., et al.
Publicado: (2012) -
Genome-wide CRISPR screen identifies protein pathways modulating tau protein levels in neurons
por: Sanchez, Carlos G., et al.
Publicado: (2021) -
Genome-wide CRISPR-Cas9 screens identify mechanisms of BET bromodomain inhibitor sensitivity
por: Estoppey, David, et al.
Publicado: (2021)